These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 824157)

  • 1. Liver microsomal drug-metabolizing enzyme system: functional components and their properties.
    Lu AY
    Fed Proc; 1976 Nov; 35(13):2460-3. PubMed ID: 824157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of hepatic microsomal drug-metabolizing systems from rats fed crude and purified diets.
    Abbott V; Deloria L; Guenthner T; Jeffery E; Kotake A; Nerland D; Mannering G
    Drug Metab Dispos; 1976; 4(3):215-22. PubMed ID: 6225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug metabolism in a reconstituted system by diabetes-dependent hepatic cytochrome P-450.
    Past MR; Cook DE
    Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):81-90. PubMed ID: 6812187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The liver microsomal hydroxylation enzyme system. Induction and properties of the functional components.
    Lu AY; Kuntzman R; Conney AH
    Front Gastrointest Res; 1976; 2():1-31. PubMed ID: 819342
    [No Abstract]   [Full Text] [Related]  

  • 5. Rate-limiting step in the reconstituted microsomal drug hydroxylase system.
    Imai Y; Sato R; Iyanagi T
    J Biochem; 1977 Nov; 82(5):1237-46. PubMed ID: 412842
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of certain vitamin deficiencies on hepatic drug metabolism.
    Zannoni VG; Sato PH
    Fed Proc; 1976 Nov; 35(13):2464-9. PubMed ID: 976490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NADPH-dependent cytochrome P-450 reduction in liver microsomes of rats of different ages with and without phenobarbital pretreatment.
    Müller D; Lübbe H; Klinger W
    Acta Biol Med Ger; 1975; 34(8):1333-7. PubMed ID: 1210995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian changes of cytochrome P-450-dependent monooxygenase system in the rat liver.
    Plewka A; Czekaj P; Kamiński M; Plewka D
    Pol J Pharmacol Pharm; 1992; 44(6):655-61. PubMed ID: 1305961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds, and endogenous substrates. IX. The formation of a 455-nm metabolite-cytochrome P-450 complex.
    Kawalek JC; Levin W; Ryan D; Lu AY
    Drug Metab Dispos; 1976; 4(2):190-4. PubMed ID: 5265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dietary lipid on drug-metabolizing enzymes.
    Wade AE; Norred WP
    Fed Proc; 1976 Nov; 35(13):2475-9. PubMed ID: 824158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of mixed-function oxidases and purified cytochrome P-450 of livers of house musk shrew, Suncus murinus.
    Mizokami K; Fukuhara M; Nohmi T; Sunouchi M; Fujimori K; Takanaka A; Omori Y
    Drug Metab Dispos; 1988; 16(1):151-5. PubMed ID: 2894946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and properties of highly purified cytochrome p-450 and NADPH-cytochrome P-450 reductase from pulmonary microsomes of untreated rabbits.
    Guengerich FP
    Mol Pharmacol; 1977 Sep; 13(5):911-23. PubMed ID: 408601
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Schistosoma mansoni infection on the hepatic drug-metabolizing capacity of mice.
    Cha YN; Edwards R
    J Pharmacol Exp Ther; 1976 Nov; 199(2):432-40. PubMed ID: 185361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of 2-hydroxyestradiol-17beta on NADPH-dependent electron transfer in rat liver microsomes in vitro (author's transl)].
    Wollenberg P; Scheulen M; Bolt HM; Kappus H; Remmer H
    Hoppe Seylers Z Physiol Chem; 1976 Mar; 357(3):351-7. PubMed ID: 8367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of phospholipid in the reconstituted liver microsomal mixed function oxidase system containing cytochrome P-450 and NADPH-cytochrome P-450 reductase.
    Autor AP; Kaschnitz RM; Heidema JK; Van der Hoeven TA; Duppel W; Coon MJ
    Drug Metab Dispos; 1973; 1(1):156-61. PubMed ID: 4149377
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical characteristics of purified beef liver NADPH-cytochrome P450 reductase.
    Arinç E; Celik H
    J Biochem Mol Toxicol; 2002; 16(6):286-97. PubMed ID: 12481304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organic compounds. Their interaction with and degradation of hepatic microsomal drug-metabolizing enzymes in vitro.
    Ivanetich KM; Lucas S; Marsh JA; Ziman MR; Katz ID; Bradshaw JJ
    Drug Metab Dispos; 1978; 6(3):218-25. PubMed ID: 26540
    [No Abstract]   [Full Text] [Related]  

  • 18. Age-related changes in hepatic microsomal drug metabolism are substrate selective.
    Rikans LE; Notley BA
    J Pharmacol Exp Ther; 1982 Mar; 220(3):574-8. PubMed ID: 7062268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interrelationship between the generation of oxygen anion-radicals and the reduction of artificial acceptors and cytochrome P-450 by NADPH-cytochrome c reductase].
    Liakhovich VV; Mishin VM; Pokrovskii AG
    Biokhimiia; 1977 Jul; 42(7):1323-30. PubMed ID: 198028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubilization of microsomal NADPH: cytochrome c reductase and cytochrome bs following the trypsin and pronase treatment.
    Kamiński Z; Kaniuga Z
    Bull Acad Pol Sci Biol; 1975; 23(2):83-6. PubMed ID: 806332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.